151539-68-3 Usage
Description
(E)-8-(2-(4-Butoxyphenyl)ethenyl)-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione is a complex chemical compound that features a purine ring system with propyl and butoxy substituents, as well as an ethenyl side chain attached to a phenyl ring. As a derivative of the purine molecule, it holds potential pharmaceutical applications as a drug or therapeutic agent, possibly exhibiting biological activities such as anti-inflammatory, antiviral, or antitumor effects. However, further research is necessary to fully comprehend its potential uses and mechanisms of action.
Uses
Used in Pharmaceutical Industry:
(E)-8-(2-(4-Butoxyphenyl)ethenyl)-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione is used as a potential drug or therapeutic agent for its possible biological activities, including anti-inflammatory, antiviral, or antitumor effects. Its unique structure and properties make it a candidate for further research and development in the pharmaceutical field.
Used in Research and Development:
In the scientific community, (E)-8-(2-(4-Butoxyphenyl)ethenyl)-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione serves as a subject of study to explore its potential applications and mechanisms of action. Researchers may investigate its interactions with biological systems and evaluate its efficacy and safety for various medical uses.
Check Digit Verification of cas no
The CAS Registry Mumber 151539-68-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,5,3 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 151539-68:
(8*1)+(7*5)+(6*1)+(5*5)+(4*3)+(3*9)+(2*6)+(1*8)=133
133 % 10 = 3
So 151539-68-3 is a valid CAS Registry Number.
InChI:InChI=1/C23H30N4O3/c1-4-7-16-30-18-11-8-17(9-12-18)10-13-19-24-20-21(25-19)26(14-5-2)23(29)27(15-6-3)22(20)28/h8-13H,4-7,14-16H2,1-3H3,(H,24,25)/b13-10+
151539-68-3Relevant articles and documents
Antidepressants
-
, (2008/06/13)
The present invention relates to an antidepressant containing as an active ingredient a xanthine derivative or a pharmaceutically acceptable salt thereof, the xanthine derivative being represented by Formula (I) : STR1 in which R1, R2, and R3 represent independently hydrogen, lower alkyl, lower alkenyl; R4 represents cycloalkyl, --(CH2)n --R5 (in which R5 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group; and n is an integer of 0 to 4), or STR2 (in which Y1 and Y2 represent independently hydrogen, halogen or lower alkyl; and Z represents substituted or unsubstituted aryl, STR3 (in which R6 represents hydrogen, hydroxy, lower alkyl, lower alkoxy, halogen, nitro, or amino; and m represents an integer of 1 to 3), or a substituted or unsubstituted heterocyclic group); and X1 and X2 represent independently O or S.
